<unk>  is an anti-angiogenic ribozyme. It is largely being studied in the treatment of kidney cancer. It may prevent the growth of blood vessels from surrounding tissue to the tumor, i.e., angiogeneis. It belongs to the families of drugs called VEGF receptor and angiogenesis inhibitors. Preliminary tests have demonstrated that Angiogenesis has no significant side effects. the Also called RPI.4610
Angiozyme
Asfotase alfa
Velmanase alfa
Sebelipase alfa
Anistreplase
Celadrin 
Aminocaproic acid
Sarin